SAFE West India 2024: India's CCTV Camera Market to reach $13.08 Billion by 2029 with CAGR of 16.9%-Bank of Baroda (BOB) reports a growth of 26.1% in its FY24 Net Profit to INR 17,789 crore-TASVA Designer Ethnic Wedding Wear Men's Brand By Aditya Birla Fashion & Retail Ltd (ABFRL) and Ace Designer Tarun Tahiliani, Unveils it's First Retail Mall Store in Mumbai-Union Bank of India Posts Q3FY24 Financial Results, Report's Stellar Performance Q3 advances grow 11.44% YoY to Rs 8.96 lakh crore-Go Digit General Insurance Limited Rs 2615 Crores IPO Opens On Wednesday 15 May 2024 Price Band Fixed At Rs 258 to Rs 272 Per Share-Navi Mumbai-based Businesswoman Shital Bhatnagar Crowned Mrs UAE International 2024, A Proud Moment For India!-Punjab National Bank (PNB) Announces Financial Results for the Quarter and Year Ended 31st March 2024-SVC Bank launches Long Term Subordinated Bonds - Series -2 At An Attractive Interest Rate of 8.50%* P.A.-Patel Engineering Limited (PEL) declared as the Lowest Bidder (L1) in a JV Project of Rs. 342.76 Crore by GoM-SAFE West India 2024 (2nd Edition) addresses India's Growing Security Market, Projected to reach USD 7.36 Billion by 2029

Aparna Pharmaceuticals Private Limited

No Picture

BUSINESS, Corporate, Finance, HOME, Hospital, Health & Pharma, INDUSTRY, Investment, NATION, PHOTO NEWS, Research & Analysis, STATE February 13, 2024

Aparna Group forays into Pharma Business Vertical, receives USFDA clearance for Aparna Pharmaceuticals manufacturing unit

HYDERABAD, 12th  FEBRUARY, 2024 (GPN)— Aparna Pharmaceuticals Private Limited, a leader in manufacturing Active Pharmaceutical Ingredients (APIs) and Advanced Drug Intermediates, is pleased to announce that its manufacturing facility, Aparna Organics Limited, located in Pydibhimavaram,…